Standout Papers
Immediate Impact
7 from Science/Nature 91 standout
Citing Papers
JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma
2024 StandoutScience
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
2023 Standout
Works of Michael I. Jesson being referenced
PF-06651600, a Dual JAK3/TEC Family Kinase Inhibitor
2019
Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550)
2011 Standout
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael I. Jesson | 657 | 464 | 264 | 496 | 21 | 1.5k | |
| Nandini Kishore | 595 | 686 | 446 | 495 | 20 | 1.9k | |
| Debra M. Meyer | 389 | 407 | 190 | 459 | 13 | 1.2k | |
| Scott Steward-Tharp | 401 | 741 | 208 | 255 | 20 | 1.3k | |
| Polly Pine | 350 | 1000 | 330 | 304 | 22 | 1.6k | |
| Emmanuel Karouzakis | 278 | 467 | 1025 | 548 | 30 | 1.9k | |
| Sarah R. Walker | 804 | 457 | 860 | 388 | 40 | 2.1k | |
| Tiffany K. Ricks | 754 | 428 | 524 | 137 | 20 | 1.7k | |
| Ulrike Benbow | 594 | 215 | 833 | 175 | 25 | 1.9k | |
| Jean S. Beebe | 305 | 403 | 628 | 248 | 38 | 1.6k | |
| Kyri Dunussi‐Joannopoulos | 303 | 1605 | 238 | 249 | 19 | 2.0k |
All Works
Login with ORCID to disown or claim papers
Loading papers...